Ginkgo Bioworks (NYSE: DNA) reported Q1 revenue $168 million versus the consensus estimate of $105.68 million.

GUIDANCE:

Ginkgo Bioworks sees FY2022 revenue of $375-390 million, versus the consensus of $333 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.